A randomized trial of adding insulin glargine vs. avoidance of insulin in people with Type 2 diabetes oneither no oral glucose-lowering agents or submaximal doses of metformin and/or sulphonylureas
Latest Information Update: 11 Apr 2018
At a glance
- Drugs Insulin glargine (Primary) ; Antihyperglycaemics
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- Acronyms INSIGHT
- Sponsors Sanofi
Most Recent Events
- 01 Apr 2018 Results of pooled analysis of Asian patients included in this and other six trials assessing the impact of patient baseline covariates on the required dose of basal insulin and treatment response for the improved management of Asian patients with type 2 diabetes published in the Diabetes Therapy